These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8136604)

  • 21. Use of HLA- and HPA--matched platelets in alloimmunized patients.
    Kekomäki R
    Vox Sang; 1998; 74 Suppl 2():359-63. PubMed ID: 9704468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients.
    Slichter SJ
    J Clin Apher; 2006 Apr; 21(1):78-84. PubMed ID: 16619231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet transfusion goals in oncology patients.
    Fasano RM; Josephson CD
    Hematology Am Soc Hematol Educ Program; 2015; 2015():462-70. PubMed ID: 26637759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of leucocyte-poor blood components and HLA-matched-platelet donors to prevent HLA alloimmunization.
    Murphy MF; Metcalfe P; Thomas H; Eve J; Ord J; Lister TA; Waters AH
    Br J Haematol; 1986 Mar; 62(3):529-34. PubMed ID: 3954967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet refractoriness and alloimmunization in pediatric oncology and bone marrow transplant patients.
    Hogge DE; McConnell M; Jacobson C; Sutherland HJ; Benny WB; Massing BG
    Transfusion; 1995 Aug; 35(8):645-52. PubMed ID: 7631404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Not just a small adult.
    Luban NL
    Transfusion; 2002 Jun; 42(6):666-8. PubMed ID: 12147016
    [No Abstract]   [Full Text] [Related]  

  • 27. [Platelet pool versus single platelet donor].
    Rev Fr Transfus Immunohematol; 1987 Nov; 30(4):293-319. PubMed ID: 2832927
    [No Abstract]   [Full Text] [Related]  

  • 28. [Leukocyte depletion of labile blood products].
    Gerota J; Cavalier J; Masse M; Waller W; Bidet ML
    Rev Fr Transfus Immunohematol; 1987; 30(2):109-34. PubMed ID: 3659740
    [No Abstract]   [Full Text] [Related]  

  • 29. Preoperative platelet transfusions and perioperative red blood cell requirements in patients with thrombocytopenia undergoing noncardiac surgery.
    Warner MA; Jia Q; Clifford L; Wilson G; Brown MJ; Hanson AC; Schroeder DR; Kor DJ
    Transfusion; 2016 Mar; 56(3):682-90. PubMed ID: 26559936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
    Levy L; Woodfield DG
    N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet transfusion prophylaxis for patients with haematological malignancies: where to now?
    Stanworth SJ; Hyde C; Brunskill S; Murphy MF
    Br J Haematol; 2005 Dec; 131(5):588-95. PubMed ID: 16351634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Roaming through methodology. XII. Pragmatic and pathophysiologic trials: a question of goal formulation].
    Algra A; van der Graaf Y
    Ned Tijdschr Geneeskd; 1999 Mar; 143(10):514-7. PubMed ID: 10321260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alloimmunization against the MHC antigens after platelet transfusions is due to contaminating leukocytes in the platelet suspension.
    Claas FH; Smeenk RJ; Schmidt R; van Steenbrugge GJ; Eernisse JG
    Exp Hematol; 1981 Jan; 9(1):84-9. PubMed ID: 7238645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet transfusions to HLA-immunized recipients: how to be or not to be matched.
    Rubinstein P
    Transfusion; 2010 Nov; 50(11):2292-4. PubMed ID: 21182628
    [No Abstract]   [Full Text] [Related]  

  • 35. Limited efficacy of universal leucodepletion in reducing the incidence of febrile nonhaemolytic reactions in red cell transfusions.
    Ibojie J; Greiss MA; Urbaniak SJ
    Transfus Med; 2002 Jun; 12(3):181-5. PubMed ID: 12071874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation of leukocyte-free platelets for transfusion by filtration through cotton wool.
    Sirchia G; Parravicini A; Rebulla P; Bertolini F; Morelati F; Marconi M
    Vox Sang; 1983; 44(2):115-20. PubMed ID: 6829183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Platelet allo-antibodies identification strategies for preventing and managing platelet refractoriness].
    Basire A; Picard C
    Transfus Clin Biol; 2014 Nov; 21(4-5):193-206. PubMed ID: 25277423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective randomized trial of HLA-matched versus mismatched single-donor platelet transfusions in cancer patients.
    Messerschmidt GL; Makuch R; Appelbaum F; Ungerleider RS; Abrams R; O'Donnell J; Holohan TV; Fontana J; Wright D; Anagnou NP
    Cancer; 1988 Aug; 62(4):795-801. PubMed ID: 3293762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet transfusion therapy.
    Aisner J
    Med Clin North Am; 1977 Sep; 61(5):1133-45. PubMed ID: 330975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demonstrating drug action.
    Tamminga CA
    Am J Psychiatry; 2004 Jun; 161(6):943-5. PubMed ID: 15169679
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.